Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone

Endocrinology

Volumn 139, Issue 2, 1998, Pages 640-650

  Tagami, Tetsuya ^a   Larry Jameson, J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MUTANT PROTEIN; NUCLEAR PROTEIN; RECEPTOR PROTEIN; REPRESSOR PROTEIN; THYROID HORMONE; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSFECTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SILENT GENE; THYROID HORMONE RESISTANCE;

EID: 15144351976     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.2.5742     Document Type: Article

References (56)

1. Jameson JL, DeGroot LJ 1995 Mechanisms of thyroid hormone action. In: DeGroot LJ (ed) Endocrinology. Saunders, Philadelphia, pp 583-601
2. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
3. 3-inducible promoters and blocks activity of the retinoic acid receptor. New Biol 1:329-336
4. Damm K, Thompson CC, Evans RM 1989 Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339:593-597
5. Baniahmad A, Steiner C, Kohne AC, Renkawitz R 1990 Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell 61:505-514
6. Naar AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, Glass CK, Rosenfeld MG 1991 The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65:1267-1279
7. Saatcioglu F, Deng T, Karin M 1993 A novel cis element mediating ligand-independent activation by c-erbA: implications for hormonal regulation. Cell 75:1095-1105
8. Hollenberg AN, Monden T, Wondisford FE 1995 Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini. J Biol Chem 270:14274-14280
9. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
10. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK 1995 Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454
11. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
12. 3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10:813-825
13. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD 1995 Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9:243-254
14. Zamir I, Harding HP, Atkins GB, Horlein A, Glass CK, Rosenfeld MG, Lazar MA 1996 A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16:5458-5465
15. 3 receptors and transcriptional corepressors. Mol Endocrinol 11:470-480
16. Tagami T, Madison LD, Nagaya T, Jameson JL 1997 Nuclear receptor co-repressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol 17:2642-2648
17. Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, DeGroot LJ 1989 Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci USA 86:8977-8981
18. Usala SJ, Tennyson GE, Bale AE, Lash RW, Gesundheit N, Wondisford FE, Accili D, Hauser P, Weintraub BD 1990 A base mutation of the c-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest 85:93-100
19. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB, Cheng SY, Weintraub BD 1992 Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3′-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6:248-258
20. Collingwood TN, Adams M, Tone Y, Chatterjee VK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1262-1277
21. Zavacki AM, Harney JW, Brent GA, Larsen PR 1993 Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol 7:1319-1331
22. Sakurai A, Miyamoto T, Refetoff S, DeGroot LJ 1990 Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-β in a family with generalized resistance to thyroid hormone. Mol Endocrinol 4:1988-1994
23. Chatterjee VKK, Nagaya T, Madison LD, Datta S, Rentoumis A, Jameson JL 1991 Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. J Clin Invest 87:1977-1984
24. Jameson JL 1994 Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormone. Thyroid 4:485-492
25. Kopp P, Kitajima K, Jameson JL 1996 Syndrome of resistance to thyroid hormone: insights into thyroid hormone action. Proc Soc Exp Biol Med 211:49-61
26. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
27. Nagaya T, Madison LD, Jameson JL 1992 Thyroid hormone receptor mutants that cause resistance to thyroid hormone. J Biol Chem 267:13014-13019
28. Chatterjee VKK, Lee JK, Rentoumis A, Jameson JL 1989 Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci USA 86:9114-9118
29. Drolet DW, Scully KM, Simmons DM, Wegner M, Chu KT, Swanson LW, Rosenfeld MG 1991 TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes Dev 5:1739-1753
30. Beck-Peccoz P, Chatterjee VK, Chin WW, DeGroot LJ, Jameson JL, Nakamura H, Refetoff S, Usala SJ, Weintraub BD 1994 Nomenclature of thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance. J Clin Endocrinol Metab 78:990-993
31. Forman BM, Yang C-R, Stanley F, Casanova J, Samuels HH 1988 c-erbA protooncogenes mediate thyroid hormone-dependent and independent regulation of the rat growth hromone and prolactin genes. Mol Endocrinol 2:902-911
32. Sadowski I, Ma J, Tiezenberg S, Ptashne M 1988 Gal4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564
33. Nagaya T, Jameson JL 1993 Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Biol Chem 268:15766-15771
34. Margolskee RF, McHendry-Rinde B, Horn R 1993 Panning transfected cells for electrophysiological studies. Biotechniques 15:906-911
35. Graham FL, van der Eb AJ 1973 Transformation of rat cells by DNA of human adenovirus 5. Virology 52:456-487
36. deWet JR, Wood KV, DeLuca M, Helinski DR 1987 Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7:725-737
37. Tone Y, Collingwood TN, Adams M, Chatterjee VK 1994 Functional analysis of a transactivation domain in the thyroid hormone beta receptor. J Biol Chem 269:31157-31161
38. Damm K, Evans RM 1993 Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha. Proc Natl Acad Sci USA 90:10668-10672
39. Seol W, Mahon MJ, Lee YK, Moore DD 1996 Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol Endocrinol 10:1646-1655
40. Hollenberg AN, Monden T, Madura JP, Lee K, Wondisford FE 1996 Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J Biol Chem 271:28516-28520
41. Nagaya T, Eberhardt NL, Jameson JL 1993 Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab 77:982-990
42. Wondisford FE, Steinfelder HJ, Nations M, Radovick S 1993 AP-1 antagonizes thyroid hormone action on the thyrotropin β-subunit gene. J Biol Chem 268:2749-2754
43. Weiss RE, Hayashi Y, Nagaya T, Petty KJ, Murata Y, Tunca H, Seo H, Refetoff S 1996 Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor. J Clin Endocrinol Metab 81:4196-4203
44. Au-Fliegner M, Helmer E, Casanova J, Raaka BM, Samuels HH 1993 The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol Cell Biol 13:5725-5737
45. 3-receptor homodimers but not receptor-auxiliary protein heterodimers. J Biol Chem 267:3565-3568
46. Yen PM, Sugawara A, Refetoff S, Chin WW 1992 New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J Clin Invest 90:1825-1831
47. Piedrafita FJ, Ortiz MA, Pfahl M 1995 Thyroid hormone receptor-β mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Mol Endocrinol 9:1533-1548
48. Hao E, Menke JB, Smith AM, Jones C, Geffner ME, Hershman JM, Wuerth JP, Samuels HH, Ways DK, Usala SJ 1994 Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities. Mol Endocrinol 8:841-851
49. Flynn TR, Hollenberg AN, Cohen O, Menke JB, Usala SJ, Tollin S, Hegarty MK, Wondisford FE 1994 A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Biol Chem 269:32713-32716
50. Kitajima K, Nagaya T, Jameson JL 1995 Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization. Thyroid 5:343-353
51. Beck-Peccoz P, Chatterjee VKK 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-232
52. Wong R, Zhu XG, Pineda MA, Cheng SY, Weintraub BD 1995 Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors. Mol Med 1:306-319
53. Hayashi Y, Weiss RE, Same DH, Yen PM, Sunthornthepvarakul T, Marcocci C, Chin WW, Refetoff S 1995 Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? J Clin Endocrinol Metab 80:3246-3256
54. Baniahmad A, Kohne AC, Renkawitz R 1992 A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J 11:1015-1023
55. Baniahmad A, Tsai SY, O'Malley BW, Tsai MJ 1992 Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses. Proc Natl Acad Sci USA 89:10633-10637
56. Yen PM, Wilcox EC, Hayashi Y, Refetoff S, Chin WW 1995 Studies on the repression of basal transcription (silencing) by artificial and natural human thyroid hormone receptor-β mutants. Endocrinology 136:2845-2851